Menu

TransMedics Group, Inc. TMDX

Full chart Compare
Set alert

Price alert · TMDX

All alert types
88.24 USD +19.26 (+27.92%)

At closeNov 6, 2026, 6:58 PM EST

88.10 -0.14 -0.16%

After hours · Nov 6, 6:58 PM ET

76.50 Day range 88.44
62.04 52-week range 150.42
YTD
-27.46%
1 year
-29.40%

Revenue & Expenses

Revenue by
Income Tax Benefit → Gross Profit & Other Income: $82.77MGross Profit & Other Income → Net Income: $190.29MGross Profit & Other Income → Selling, General & Admin: $185.17MGross Profit & Other Income → Research & Development: $69.06MGross Profit & Other Income → Other Expenses: $1.06MProduct → Revenue: $372.40MGross Profit → Gross Profit & Other Income: $362.81MRevenue → Gross Profit: $362.81MRevenue → Cost of Revenue: $242.69MService Revenue → Revenue: $233.09MIncome Tax Benefit$82.77MGross Profit$362.81MCost of Revenue$242.69MGross Profit & Other Income$445.57MNet Income$190.29MSelling, General & Admin$185.17MResearch & Development$69.06MOther Expenses$1.06MRevenue$605.49MProduct$372.40MService Revenue$233.09M

Latest period ending Dec 31, 2025 · select a line to chart its full history

TMDX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
605.49M441.54M241.62M93.46M30.26M
362.81M262.08M154.09M65.27M21.16M
108.58M37.50M-28.73M-31.44M-39.43M
190.29M35.46M-25.03M-36.23M-44.22M
4.871.01-0.77-1.23-1.60
TMDX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
488.87M337.15M395.31M201.68M26.08M
1.07B804.08M706.05M277.15M134.89M
595.27M575.47M568.85M89.77M67.04M
519.28M518.29M515.95M67.56M43.80M
473.10M228.60M137.20M187.38M67.85M
TMDX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
192.84M48.80M-13.03M-45.82M-28.86M
-59.25M-129.30M-193.95M54.51M29.27M
16.86M22.87M400.42M167.93M1.39M
-59.25M-129.74M-151.85M-11.91M-3.52M
151.72M-58.16M193.63M175.60M999.00K